首页
学习
活动
专区
圈层
工具
发布
首页
学习
活动
专区
圈层
工具
MCP广场
社区首页 >专栏 >Healthvana的数字COVID-19疫苗接种记录关于交流而非免疫护照

Healthvana的数字COVID-19疫苗接种记录关于交流而非免疫护照

作者头像
木樾233
修改于 2021-01-15 08:59:04
修改于 2021-01-15 08:59:04
7090
举报

随着针对COVID-19的疫苗接种的进行(尽管起步艰难),许多公司正在尝试以各种方式支持推广。 Healthvana是一家健康科技初创公司,最初专注于为艾滋病病毒感染者提供数字化患者信息,目前正在使用苹果的Wallet技术帮助洛杉矶县推出COVID-19的移动疫苗记录。对这项技术的实施情况进行的粗略评估可能会导致人们认为这是关于为个人提供容易的疫苗接种证明,但是该技术和Healthvana专注于告知个人以确保他们参与自己的医疗保健计划,而不是提供免疫力通过。

Healthvana首席执行官兼创始人Ramin Bastani表示:“我通常认为大多数医疗保健软件的外观和感觉都类似于Windows95。” “我们看起来和感觉都像Instagram。为什么这么重要?因为患者可以从事他们了解的事情,所以他们习惯于交流的方式更容易交流,最终导致他们获得更好的健康结果。”

Bastani指出,他们是通过将这种方法用于艾滋病毒患者教育和交流的重点而成立公司的,并证明使用软件可以使患者下次接受随访的可能性比接受随访的患者高7.4倍。通过传统方法获取信息和约会通知。该公司已经建立了他们的工具和方法,不仅通过为个人提供更好的健康,而且还通过消除对消除误会并从实质上束缚患者的后续工作的大量工作的需要,从而降低了医疗保健提供者的成本。可以极大地挖掘临床医生和护理人员的时间。

“实际上,我们还降低了医疗服务提供者的成本,因为您没有1000个人打电话询问他们的结果是什么,并说'我不明白,我无法登录,我不知道“ SARS不反应意味着什么,”或我们通过简单性解决的所有问题,” Bastani说。 “这带来了巨大的改变。总的来说,我认为所有医疗保健的关键将是能够引起患者的注意,并采取措施应对其健康状况。”

这也是Healthvana与LA County在COVID-19免疫记录上建立合作伙伴关系的目标-采取至关重要的行动,以确保成功实施其疫苗接种计划。迄今为止,所有已批准的COVID-19疫苗都需要进行两疗程的治疗,包括一次初次接种,然后在以后的某个时间加强接种。该合作的主要目的是让LA县居民了解他们的COVID-19疫苗接种情况以及何时需要第二次接种疫苗,这是该合作伙伴关系的主要目的,并且受益于Healthvana在改善患者随访活动方面的经验。但是该应用程序还向用户提供有关COVID-19护理的信息,以及最有用的预防方法和减慢传播速度的方法。

尽管Bastani强调说,Healthvana最终只是消息传递的“最后一英里”,并且在确定正确的步骤以进行适当的护理和预防时还涉及许多其他层面,但是它们提供可操作信息的方式已经事实证明,这是一项关键措施的一大福音:联系追踪。在某些城市,Healthvana还将提示测试结果为肯定的用户直接从其设备匿名通知近距离联系人,这将为这些人提供免费的测试选项和信息资源。

Bastani说:“仅在大洛杉矶地区开展这项活动不到两个月,我们就收到12,000多人被暴露的消息。” “他们每个人都可能与其他人和家庭住在一起-这就是您可以帮助减缓传播的方法。”

与之形成对比的是,Google和Apple通过罕见的合作提供的最新软件更新,对iOSAndroid设备中内置的曝光通知工具的吸收相对较慢。尽管作为基础的技术是健全的,并且专注于用户隐私,但到目前为止,其使用数量还远远没有动摇。例如,自启动以来,三个月内只有388人通过弗吉尼亚州的应用程序基于曝光通知框架发送了警报。

Healthvana专注于及时和相关的信息传递,以他们最有可能理解和参与的方式提供给用户,这已经显示出其对COVID-19及其社区传播产生影响的能力。这家初创公司已经在商讨在该国其他地方启动类似计划的问题,这可能有助于改善国家的疫苗接种效果,以及人们一旦获得COVID-19的方式也将得到改善。

Healthvana’s digital COVID-19 vaccination records are about communication, not passports for the immune

As the vaccination campaign to counter COVID-19 gets underway (albeit with a rocky start), a number of companies are attempting to support its rollout in a variety of ways. Healthvana, a health tech startup that began with a specific focus on providing patient information digitally for individuals living with HIV, is helping Los Angeles County roll out mobile vaccination records for COVID-19 using Apple’s Wallet technology. A cursory appraisal of the implementation of this tech might lead one to believe it’s about providing individuals with easy proof of vaccination — but the tech, and Healthvana,  are focused on informing individuals to ensure they participate in their own healthcare programs, not providing an immunity pass.

“I generally consider most of healthcare to look and feel like Windows 95,” Healthvana CEO and founder Ramin Bastani said. “We look and feel like Instagram . Why is that important? Because patients can engage in things they understand, it’s easier for them to communicate in the way they’re used to communicating, and that ends up leading them to better health outcomes.”

Bastani points out that they began the company by focusing this approach to patient education and communication on HIV, and demonstrated that using their software led to patients being 7.4 times more likely to show up for their next follow-up appointment versus patients who received follow-up information and appointment notices via traditional methods. The company has built their tooling and their approach around not only producing better health for individuals, but also on reducing costs for healthcare providers by eliminating the need for a lot of the work that goes into clearing up misunderstandings, and essentially hounding patients to follow-up, which can significantly dig into clinician and care staff hours.

“We’re actually also reducing the cost to healthcare providers, because you don’t have 1,000 people calling you asking what are their results, and saying ‘I don’t understand, I can’t log in, I don’t know what it means to be SARS nonreactive,’ or all those things we address through simplicity,” Bastani said. “That’s made a huge difference. Overall, I think the key to all healthcare is going to be to be able to get patients to pay attention, and take action to things around their health.”

That’s the goal of Healthvana’s partnership with LA County on COVID-19 immunization records, too — taking vitally important action to ensure the successful rollout of its vaccination program. All approved COVID-19 vaccines to date require a two-course treatment, including one initial inoculation followed by a booster to be administered sometime later. Keeping LA county residents informed about their COVID-19 inoculation, and when they’re due for a second dose, is the primary purpose of the partnership, and benefits from Healthvana’s experience in improving patient follow-up activities. But the app is also providing users with information about COVID-19 care, and, most usefully, prevention and ways to slow the spread.

While Bastani stresses that Healthvana is, in the end, just “the last mile” for message delivery, and that there are many other layers involved in determining the right steps for proper care and prevention, the way in which they provide actionable info has already proven a big boon to one key measure: contact tracing. In select municipalities, Healthvana will also prompt users who’ve tested positive to anonymously notify close contacts directly from their device, which will provide those individuals with both free testing options and information resources.

“Just us doing this in the greater Los Angeles area for less than two months, 12,000+ people have been notified that they’ve been exposed,” Bastani said. “Each of them likely lives with other people and families — this is how you can help slow the spread.”

Contrast that with the relatively slow uptake of the exposure notification tools built into iOS and Android  devices via recent software updates provided by Google and Apple working in a rare collaboration. While the technology that underlies it is sound, and focused on user privacy, its usage numbers thus far are far from earthshaking; only 388 people have sent alerts through Virginia’s app-based on the exposure notification framework in three months since its launch, for instance.

Healthvana’s focus on timely and relevant delivery of information, offered to users in ways they’re mostly likely to understand and engage with, is already showing its ability to have an impact on COVID-19 and its community transmission. The startup is already in talks to launch similar programs elsewhere in the country, and that could help improve national vaccination outcomes, and how people handle COVID-19 once they have it, too.

本文系外文翻译,前往查看

如有侵权,请联系 cloudcommunity@tencent.com 删除。

本文系外文翻译,前往查看

如有侵权,请联系 cloudcommunity@tencent.com 删除。

评论
登录后参与评论
暂无评论
推荐阅读
编辑精选文章
换一批
Gut|揭示肠道微生物与COVID-19疫苗免疫效果及母婴保护的关键联系
近日,广东药科大学公共卫生学院陈青松、付曦团队,在国际著名学术期刊Gut(影响因子24.5)发表了题为 “Exploring the impact of gut microbial metabolites on inactivated SARS-CoV-2 vaccine efficacy during pregnancy and mother-to-infant antibody transfer ”的论文,揭示孕妇孕期肠道微生物与COVID-19疫苗免疫效果以及对母婴健康保护之间的关键联系。
生信宝典
2023/09/28
2000
Gut|揭示肠道微生物与COVID-19疫苗免疫效果及母婴保护的关键联系
年轻的企业家带来高科技来平息对外科手术的恐惧
乔治·克拉姆(George Kramb)最不希望看到的是,多年来,外科医生一直在使用医疗设备进行实际手术,他要扮演的角色是帮助全世界的患者完成他们自己的医疗旅程。
柴艺
2021/01/15
4540
COVID-19患者免疫反应的单细胞景观
2019年冠状病毒疾病(COVID-19)由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染引起,疾病严重程度与宿主免疫反应之间的关系并没有一个很好的理解。在此,本文对5名健康献血者和13名COVID-19患者的外周血样本进行了单细胞RNA测序,包括中度、重度和恢复期病例。
生信交流平台
2020/09/14
6520
COVID-19患者免疫反应的单细胞景观
问问Siri你是否感染了新冠病毒
公司于周天推出了自我筛选功能——允许用户询问,“Siri,我是否患有新冠肺炎?”如果用户有一些症状,例如发烧,干咳,气短等,或者说如果他们接触过新冠病人,siri便会引导用户完成由美国疾病防控中心和美国公共健康服务准备的调查问卷。
zstt8054929
2020/12/10
6950
文献解读-流行病学-第九期|《与Covid-19严重程度相关的免疫基因先天性缺陷的罕见变异》
宿主遗传因素已被证明在SARS-CoV-2感染和Covid-19疾病过程中具有重要作用。影响Covid-19易感性和严重程度的常见变异的遗传贡献已经在不同人群中进行了广泛研究。然而,对于先天性免疫缺陷引起的罕见遗传变异的研究相对较少,尤其是在中国人群中。
INSVAST
2024/06/13
1490
文献解读-流行病学-第九期|《与Covid-19严重程度相关的免疫基因先天性缺陷的罕见变异》
大数据公司Palantir开发新软件,帮助美国政府追踪新冠疫苗情况
全球最神秘的大数据公司Palantir最近有新消息曝出,一直在帮助联邦卫生部门开发一款可以用来管理各种疫苗数据、并发现可能阻止注射情况的软件。
大数据文摘
2020/10/30
6230
大数据公司Palantir开发新软件,帮助美国政府追踪新冠疫苗情况
[医疗信息化][DICOM教程]开篇介绍,新冠肺炎为医疗保健信息产业带来新的的紧迫性
The ongoing COVID-19 pandemic and the tragedies that have occured (and still occuring) have helped highlight the need for more timely exchange of critical healthcare related information for governments, health agencies, care providers and patients around the world. For many decades, the healthcare community has been at the forefront of standardization efforts for information exchange through the use of communication protocols such as HL7 and DICOM, and has worked hard to promote the use of these standards worldwide. However, the recent experience only highlights the fact that more opportunities exist to help achieve even more synergies and efficiencies in the information exchange processes that need to occur between various systems involved in the overall process of planning, administering, receiving and monitoring of all healthcare-related activities that are operationalized at any moment.
landv
2020/08/05
9060
文献解读-Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large
新冠疫情爆发以来,疫苗的开发和应用成为全球应对COVID-19的关键策略。其中,BNT162b2 mRNA疫苗因其快速开发和高效性而备受关注。然而,随着时间推移和新变异株的出现,评估疫苗的长期有效性变得至关重要。为此,研究人员进行了一项大规模研究,旨在评估BNT162b2疫苗在实际使用中的长期有效性。
INSVAST
2025/01/09
1280
文献解读-Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large
COVID-19患者恢复阶段的单细胞免疫图谱
今天分享的文献是2020年5月4日,在Cell Discovery杂志上在线发表题为“Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing” 的研究论文。
生信技能树jimmy
2020/07/01
1.1K0
诺奖力量 | 单细胞测序释放mRNA疫苗的澎湃潜力
2023年诺贝尔生理学或医学奖授予Katalin Karikó和Drew Weissman,以表彰他们在核苷碱基修饰方面的发现,这些发现使得针对COVID-19的有效mRNA疫苗得以快速开发。高度可编程的mRNA疫苗,是保护我们免受COVID-19等快速进化病毒侵袭的强大工具。
生信技能树jimmy
2023/10/06
3630
诺奖力量 | 单细胞测序释放mRNA疫苗的澎湃潜力
Nat.Mach.Intell.|COVID-19死亡率预测模型系列评论及作者回复
今天给大家介绍2020年11月12日发表在Nature Machine Intelligence上的三篇评论。这三篇评论都缘于该期刊往期的一篇标题为“An interpretable mortality prediction model for COVID-19 patients”的文章,评论主要抨击了原文章提出的对于COVID-19患者的死亡率预测模型所存在的问题。同时,该期刊同期发表了原作者li Yan等人对该三篇评论的回复。
DrugAI
2021/02/02
4130
Nat.Mach.Intell.|COVID-19死亡率预测模型系列评论及作者回复
原创译文 | AI检测眼部疾病有了重大突破,人工智能医疗不再是噱头
本文为灯塔大数据原创内容,欢迎个人转载至朋友圈,其他机构转载请在文章开头标注:“转自:灯塔大数据;微信:DTbigdata”
灯塔大数据
2018/08/28
5950
原创译文 | AI检测眼部疾病有了重大突破,人工智能医疗不再是噱头
IBM、微软与医疗保健的未来
https://www.technewsworld.com/story/86911.html
zstt8054929
2020/12/23
3880
来自世界各地的科技领袖和卫生当局合作抗击COVID-19
Linux基金会是一个通过开源实现大规模创新的非盈利组织,今天发起了一项新的倡议,利用开源技术帮助世界各地的公共卫生部门(public health authorities,PHAs)抗击COVID-19和未来的流行病。新的LFPH(Linux Foundation Public Health,Linux基金会公共卫生)倡议是由七个主要成员发起的——Cisco、doc.ai、Geometer、IBM、NearForm、腾讯、以及VMware。还有两个暴露通知的托管项目,COVID Shield和COVID Green,目前正在加拿大、爱尔兰和美国几个州部署。
CNCF
2020/07/22
5940
来自世界各地的科技领袖和卫生当局合作抗击COVID-19
区块链深入“健康码”验证、疫苗打假
近日,新加坡政府技术局(GovTech)与卫生部(MOH)合作开发了一套基于区块链的文件验证系统,以提供 COVID-19 阴性检测证明。
深度学习与Python
2021/03/12
7860
区块链深入“健康码”验证、疫苗打假
AI用于COVID-19的药物发现和疫苗开发
SARS-COV-2号召科学界采取行动,以对抗日益增长的大流行病。撰写本文时,还没有新型抗病毒药或批准的疫苗可用于部署作为一线防御。了解COVID-19的病理生物学特性可通过阐明未探索的病毒途径来帮助科学家发现有效的抗病毒药。实现这一目标的一种方法是利用计算方法在计算机上发现新的候选药物和疫苗。过去的十年中,基于机器学习的模型在特定的生物分子上进行了训练,为发现有效的病毒疗法提供了廉价且快速的实施方法。给定目标生物分子,这些模型能够以基于结构的方式预测候选抑制剂。如果有足够的数据提供给模型,则可以通过识别数据中的模式来帮助寻找候选药物或疫苗。
DrugAI
2021/02/02
6980
AI用于COVID-19的药物发现和疫苗开发
COVID-19病人支气管免疫细胞单细胞测序分析
与COVID-19严重性相关的呼吸免疫特性目前还不清楚。作者选了COVID-19严重程度不同的患者以及健康人的支气管肺泡灌洗液免疫细胞,进行单细胞转录组测序。发现重度患者的支气管肺泡灌洗液中富含巨噬细胞,普通型患者的特点是存在高度克隆扩增的CD8+ T细胞。
生信技能树jimmy
2020/06/24
1.8K0
COVID-19病人支气管免疫细胞单细胞测序分析
争议! 新冠患者体内的抗体只能维持60天?
近期,医学顶级期刊《新英格兰医学杂志》(New England Journal of Medicine,NEJM)发表多篇letter形式的文章,这些文章主要讨论在中度病情的新冠患者中抗体逐渐消失的情况。米老鼠觉得有必要和大家介绍一下,因为这和以后的新冠疫苗接种也有一定的关系。
生信与临床
2022/08/21
3880
争议! 新冠患者体内的抗体只能维持60天?
奥密克戎 | 长新冠或可造成性损害| MedChemExpress
在世界范围内,新冠感染的幸存者现已超过数亿人,然而大量患者在数月后仍未完全康复,这种情况通常被称为新冠长期症状 (Long COVID,简称长新冠)。世界卫生组织将长新冠定义为:SARS-CoV-2 感染 3 个月后症状持续存在 (至少持续 2 个月),且这种症状无法用其他疾病来解释[1]。长新冠 (或称新冠急性后遗症) 是一种多系统疾病,其特点是症状和体征多样,(目前发现有 200 多种症状),包括 ME/CFS (肌痛性脑脊髓炎/慢性疲劳综合征)、自主神经障碍、对多个器官系统的影响以及血管和凝血异常。在对武汉的 1733 名住院患者的随访研究中发现,感染后 6 个月,63% 的患者报告有疲劳感,26% 有呼吸困难,5-9% 有胸痛和心悸。到 12 个月时,同一研究的调查人员显示,呼吸困难 (30%) 和胸痛 (7%) 的症状略为普遍,而疲劳感有所改善 (20%)[1]。
MedChemExpress
2023/03/29
2600
奥密克戎 | 长新冠或可造成性损害| MedChemExpress
五项需要拥抱的新时代技术
健康和公共安全的未来将由组织如何采用现代数字技术来提高运作效率、多机构协作和决策来确定。
用户8054111
2020/12/14
2600
推荐阅读
相关推荐
Gut|揭示肠道微生物与COVID-19疫苗免疫效果及母婴保护的关键联系
更多 >
领券
问题归档专栏文章快讯文章归档关键词归档开发者手册归档开发者手册 Section 归档